Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy

World Journal of Gastroenterology

Volumn 21, Issue 4, 2015, Pages 1207-1215

  Yamamoto, Yusuke ^a   Ikoma, Hisashi ^a   Morimura, Ryo ^a   Konishi, Hirotaka ^a   Murayama, Yasutoshi ^a   Komatsu, Shuhei ^a   Shiozaki, Atsushi ^a   Kuriu, Yoshiaki ^a   Kubota, Takeshi ^a   Nakanishi, Masayoshi ^a   Ichikawa, Daisuke ^a   Fujiwara, Hitoshi ^a   Okamoto, Kazuma ^a   Sakakura, Chouhei ^a   Ochiai, Toshiya ^b   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Early recurrence; Hepatectomy; Hepatocellular carcinoma; Late recurrence; Minimum P value approach

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN;

ADRENAL METASTASIS; ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BONE METASTASIS; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EARLY CANCER RECURRENCE; FEMALE; FOLLOW UP; HUMAN; LATE CANCER RECURRENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIMARY TUMOR; PROTEIN BLOOD LEVEL; REFERENCE VALUE; RETROSPECTIVE STUDY; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84921811027     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i4.1207     Document Type: Article

References (32)

1. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16 [PMID: 15508102 doi: 10.1053/j.gastro.2004.09.011]
2. Wu CC, Cheng SB, Ho WM, Chen JT, Liu TJ, P'eng FK. Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg 2005; 92: 348-355 [PMID: 15672423 doi: 10.1002/bjs.4838]
3. Yamamoto Y, Ikoma H, Morimura R, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience. Anticancer Res 2013; 33: 5097-5105 [PMID: 24222155]
4. Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111: 720-726 [PMID: 8780578 doi: 10.1053/gast.1996.v111.pm8780578]
5. Hayashi M, Shimizu T, Hirokawa F, Inoue Y, Komeda K, Asakuma M, Miyamoto Y, Takeshita A, Shibayama Y, Tanigawa N. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma. Am Surg 2011; 77: 572-578 [PMID: 21679590]
6. Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006; 202: 275-283 [PMID: 16427553 doi: 10.1016/j.jamcollsurg.2005.10.005]
7. Park JH, Koh KC, Choi MS, Lee JH, Yoo BC, Paik SW, Rhee JC, Joh JW. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg 2006; 192: 29-33 [PMID: 16769271 doi: 10.1016/j.amjsurg.2005.11.010]
8. Lu X, Zhao H, Yang H, Mao Y, Sang X, Miao R, Xu Y, Du S, Xu H, Chi T, Yang Z, Zhong S, Huang J. A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. J Surg Oncol 2009; 100: 488-493 [PMID: 19653238 doi: 10.1002/jso.21354]
9. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Makuuchi M. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996; 83: 1219-1222 [PMID: 8983610 doi: 10.1002/bjs.1800830913]
10. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000; 89: 500-507 [PMID: 10931448 doi: 10.1002/1097-0142(20000801)89]
11. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-207 [PMID: 12547409 doi: 10.1016/S0168-8278(02)00360-4]
12. Ibrahim S, Roychowdhury A, Hean TK. Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Am J Surg 2007; 194: 17-22 [PMID: 17560903 doi: 10.1016/j.amjsurg.2006.06.051]
13. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649 [PMID: 4541913 doi: 10.1002/bjs.1800600817]
14. Couinaud C. [Liver lobes and segments: notes on the anatomical architecture and surgery of the liver ]. Presse Med 1954; 62: 709-712 [PMID: 13177441]
15. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S. Surgery for small liver cancers. Semin Surg Oncol 1993; 9: 298-304 [PMID: 8210909 doi: 10.1002/ssu.2980090404]
16. Liver Cancer study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 2nd English ed.Tokyo: Kanehara, 2003: 13-28
17. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-1964 [PMID: 17008531 doi: 10.1126/science.1129139]
18. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994; 86: 829-835 [PMID: 8182763 doi: 10.1093/jnci/86.11.829]
19. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta radiol 1953; 39: 368-376 [PMID: 13057644 doi: 10.3109/00016925309136722]
20. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16: 1367-1371 [PMID: 1332922 doi: 10.1002/hep.1840160611]
21. Poon RT, Ng IO, Fan ST, Lai EC, Lo CM, Liu CL, Wong J. Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 2001; 19: 3037-3044 [PMID: 11408499]
22. Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, Aloia TA. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg 2013; 17: 66-77; discussion p.77 [PMID: 22948836 doi: 10.1007/s11605-012-2005-4]
23. Shimada K, Sakamoto Y, Esaki M, Kosuge T, Morizane C, Ikeda M, Ueno H, Okusaka T, Arai Y, Takayasu K. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2007; 14: 2337-2347 [PMID: 17503155 doi: 10.1245/s10434-007-9415-7]
24. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917 [PMID: 14667750 doi: 10.1016/S0140-6736(03)14964-1]
25. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000; 356: 802-807 [PMID: 11022927 doi: 10.1016/S0140-6736(00)02654-4]
26. Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 2002; 3: 593-603 [PMID: 12372721 doi: 10.1016/S1470-2045(02)00873-2]
27. Lau WY, Lai EC, Leung TW, Yu SC. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg 2008; 247: 43-48 [PMID: 18156922 doi: 10.1097/SLA.0b013e3181571047]
28. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, Perrin H, Azoulay D. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-701; discussion 701-703 [PMID: 9409568 doi: 10.1097/00000658-199712000-00006]
29. Printz C. Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM). Cancer 2009; 115: 4646 [PMID: 19806596 doi: 10.1002/cncr.24673]
30. Kudo M. Adjuvant therapy after curative treatment for hepatocellular carcinoma. Oncology 2011; 81 Suppl 1: 50-55 [PMID: 22212936 doi: 10.1159/000335636]
31. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 1996; 334: 1561-1567 [PMID: 8628336 doi: 10.1056/NEJM199606133342402]
32. Singal AK, Freeman DH, Anand BS. Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma. Aliment Pharmacol Ther 2010; 32: 851-858 [PMID: 20659285 doi: 10.1111/j.1365-2036.2010.04414.x]